Long term outcome of skull-base chondrosarcoma patients treated with high-dose proton therapy with or without conventional radiation therapy.

Date publication

juillet 2018

Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr NOEL Georges

Tous les auteurs :
Weber DC, Murray F, Combescure C, Calugaru V, Alapetite C, Albertini F, Bolle S, Goudjil F, Pica A, Walser M, Mammar H, Bachtiary B, Lomax T, Noël G, Dendale R, Feuvret L

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/30021697

Résumé

Skull-base chondrosarcoma (ChSa) is a rare bone tumor and the outcome of patients with this malignancy has been documented only in a limited number of series with a restricted number of patients.

Mots clés

Chondrosarcoma, Distant failure, Local tumor control, Proton therapy, Radiation induced toxicity, Skull-base tumor

Référence

Radiother Oncol. 2018 Jul 16;: